Epilepsy Association of Utah

Epilepsy Medication

New Avenues for Treatment Supported


New avenues for treatment supported
SALT LAKE CITY, Monday, August 26, 2013 – The
Epilepsy Association of Utah (EAU) recognizes the potent nature and reputation
cannabis has gained in recent news.  While
the EAU does not condone the abuse of marijuana or recreational use of marijuana,
we note the medical value and potential the extraction of Cannabidiol (CBD)
from the plant has for the epilepsy community. 
“This isn’t a political
issue and it isn’t an ethical issue; this is a medical and public policy
issue,” says Jennifer May, EAU Professional Advisory Board Member.  She continued, “I never imagined I’d be
advocating for high-CBD cannabis, but watching my son seize every day has
forced me to become educated and realize the potential this plant extract has
for changing lives.”
The EAU believes there is
great benefit in the support of any legislative measures allowing the expansion
of treatment options, specifically any medical grade product derived from the
cannabis plant.
Founded in 1973, The Epilepsy Association
of Utah is a 501(c)(3) charity dedicated to enhancing the quality of life for
all individuals living with Epilepsy and seizure disorders. 1 in 26 people will
develop Epilepsy at some time in their lives leading to over 100,000 people in
Utah alone. Epilepsy is the 4th most common neurological disorder in
the US after migraine, stroke and Alzheimer’s. The Epilepsy Association of Utah
offers a public education program, statewide support groups, personal and
professional advocacy, college scholarships, art exhibits, educational
conferences, summer camp and more.  Visit
http://epilepsyut.org for additional information.
Contact:        Annette Maughan
Email:                        annette@epilepsyut.org
Website:                  www.epilepsyut.org